# Modulating Effects of Lisinopril on Sildenafil Activity in Pulmonary Arterial Hypertension(PAH)( MELISSA)

> **NCT01181284** · — · COMPLETED · sponsor: **Mayo Clinic** · enrollment: 24 (actual)

## Conditions studied

- Pulmonary Arterial Hypertension

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01181284
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2008-05
- **Primary completion:** 2011-07
- **Final completion:** 2011-07
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2012-02-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01181284

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01181284, "Modulating Effects of Lisinopril on Sildenafil Activity in Pulmonary Arterial Hypertension(PAH)( MELISSA)". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01181284. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*